James Heaf Herlev Hospital University of Copenhagen

Slides:



Advertisements
Similar presentations
When Using DOPPS Slides. DOPPS Slide Use Guidelines.
Advertisements

M ETABOLIC S YNDROME IN P ERIONIAL D IALYSIS Dr. Sreelatha Calicut.
Dr. Leonid Feldman Nephrology and Hypertension Division Assaf Harofeh Medical Center November, 2007 Peritoneal Dialysis.
The Importance of Residual Renal Function Dr Paul Tam June 11, 2010.
This Power Point presentation belongs to the Danish Renal Registry, which owns the copyright. It can be freely used for non-commercial study and educational.
Renal Replacement Therapy: What the PCP Needs to Know.
Chronic Kidney Disease in the Elderly Patient: Less May Be More Theodore F. Saad, MD Nephrology Associates, PA Chief, Section of Renal & Hypertensive Diseases.
Peritoneal Dialysis Adequacy & Prescription Management
Cheaper Kidney Care Vs. Redesigning kidney services to improve patient choice, shared decision making and deliver NHS costing savings.
Reference Avram MM, et al. Hemoglobin predicts long-term survival in dialysis patients: a 15-year single-center longitudinal study and a correlation trend.
Finnish Registry of Kidney Disease, FRKD Quality Registries Meeting Stockholm, December 8th-9th, 2014 presented by: Carola Grönhagen-Riska (chair of the.
Chapter 12: USRDS Special Study Center on Transition of Care in CKD 2014 ANNUAL DATA REPORT VOLUME 1: CHRONIC KIDNEY DISEASE.
Therapy Modality: Automated Peritoneal Dialysis (APD)
What is the Role of Peritoneal Dialysis in Optimising ESRD Patient Outcomes?
Anatomy and Physiology of Peritoneal Dialysis
Feast or Famine: Survival and Chronic Kidney Disease Kerin Worley and Deb Gipson UNC Chapel Hill April, 2004.
CHAPTER 12 Peritoneal Dialysis Sunita Bavanandan Lily Mushahar Anita Bhajan Manocha Source: 20 th MDTR Report 2012, NRR.
Outcome of patients started on PD as first line therapy, Saira Usama, Jamal S. Alwakeel, Ahmad H. Mitwalli, Abdulkareem Alsuwaida, Akram Askar, King Khalid.
Associated Professor of Internal Medicine and Nephrology
Peritoneal Dialysis for Elderly Patients: A Review Source: Tesar V. Peritoneal dialysis in the elderly—is its underutilization justified? Nephrol Dial.
ANZDATA Registry Annual Report 2013 Philip Clayton CHAPTER 9 KIDNEY DONATION 2013 Annual Report - 36th Edition PERITONEAL DIALYSIS CHAPTER 6.
Quality Improvement on Pediatric Peritoneal Dialysis (PPD) Appropriate organization of PN Center Quality reassurance in PPD (guidelines) Evaluation of.
PERITONEAL MEMBRANE CHARACTERISTICS IN SAUDI PATIENTS Prof. Jamal Alwakeel, Dr Saira Usama Dr Abdulkareem Alsuwaida, Dr Mohammad AL Ghonaim, Dr Akram.
Renal Medicine David Johnson Princess Alexandra Hospital Brisbane, Australia A Comparison of APD vs CAPD on Patient Outcomes A Comparison of APD vs CAPD.
Principles and Techniques of Dialysis. Introduction 2 basic techniques – haemo or peritoneal Several refinements within these Haemo –Dialysis –Filtration.
Advanced CKD Study Daniel Ford UKRR Annual Audit Meeting June 2009.
Dialysis: outcome and complications. Introduction Outcomes – 20%+ of dialysis patients die each year, 3YS diabetics ~50% Technical complications –PD –Haemo.
Haemodialysis Vascular Access: Recent Trends From ANZDATA Dr Kevan Polkinghorne Monash Medical Centre ANZSN September 2007.
Prescription of pediatric peritoneal dialysis
Data completeness reporting Alex Hodsman, David Bull, Paul Dawson UK Renal Registry.
A Comparison of Sevelamer and Calcium-Based Phosphate Binders on Mortality, Hospitalization, and Morbidity in Hemodialysis: A Secondary Analysis of the.
Excessive fluid is not needed: So why is Dr. Durward so wasteful? Timothy E Bunchman MD Professor & Director Pediatric Nephrology
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 6: Mortality.
“Adequacy in PD prescription What, How, When?
Predialysis education: some cliffhangers. Transplantation Renal Replacement Therapy Hemodialysis Peritoneal Dialysis Options for End-Stage Renal Disease.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 10: Dialysis Providers.
USRDS 1999 Point Prevalence Counts by Modality, Data Source, and Year, Count (1000s) Year Center Hemo Functioning Transplant PD Home Hemo Facility.
What happens to patients returning to dialysis after transplant failure? Data from the UK Renal Registry Dr Lynsey Webb 1, Dr Anna Casula 1, Dr Charlie.
Chapter 3 Death and Survival on Dialysis Wong Hin Seng Ong Loke Meng Source: 20 th MDTR Report 2012, NRR.
Principles of Peritoneal Dialysis
The balANZ Trial. Source Johnson DW, Clarke M, Wilson V, et al. Rationale and design of the balANZ trial: a randomised controlled trial of low GDP, neutral.
Date of download: 6/2/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Similar Outcomes With Hemodialysis and Peritoneal.
Chronic Haemodialysis therapy in octogenarians with ESRF: demographics and outcomes from a single centre in England Dr Punit Yadav Dr Jyoti Baharani.
Assessing Peritoneal Barrier Function Role of the PET in Ongoing Management of PD Patients
Am J Kidney Dis. 2014;63(6): R3 박세정 /prof. 이태원 Comparative Effectiveness of Early Versus Conventional Timing of Dialysis Initiation in Advanced.
Long Term Peritoneal Dialysis In Children – Frequent Complications Conclusions: Peritoneal Dialysis is the method of choice for pediatric patients, with.
Parathyroidectomy Danish Renal Registry James Heaf.
When Using DOPPS Slides. DOPPS Slide Use Guidelines.
2016 Annual Data Report, Vol 2, ESRD, Ch 6
Present and Future of Peritoneal Dialysis
Prof. Dr. med. Vedat Schwenger
Dansk Nefrologi James Heaf2, Søren Schwartz Sørensen, Karin Skov3, Eirild Espersen3, Claus Bistrup4 Rigshospitalet, Herlev Hospital, Aarhus Universitetshospital,
Figure 10.1 Dialysis unit counts, by unit affiliation, 2011–2014
First-year death rates by modality figure 8
Prevalence (pmp) of Renal Replacement Therapy
Therapy Modality: Continuous Ambulatory Peritoneal Dialysis (CAPD)
The ADEMEX Trial Adequacy of PD in Mexico Reference
The CANUSA Trial Reference
CHAPTER 3 Death and Survival on Dialysis
Study sample selection process.
Use of icodextrin in high transport ultrafiltration failure
A Six-hour Hemodialysis Without a Significant Increase in Dialysis Dose, as Judged by Kt/V, Can Reduce the Dosage of Erythropoietin Department of Kidney.
Volume 64, Pages S3-S12 (December 2003)
Glucose sparing in peritoneal dialysis: Implications and metrics
Ali K. Abu-Alfa, John Burkart, Beth Piraino, Joe Pulliam, Salim Mujais 
Volume 78, Issue 6, Pages (September 2010)
Scatterplots showing the association between the three peritoneal equilibration test (PET) parameters. Scatterplots showing the association between the.
Forest plot showing the association between center-level characteristics and death-censored technique failure after adjusting for age, sex, race, body.
Review of clinical trial experience with icodextrin
ANZDATA Peritoneal Dialysis Report
Presentation transcript:

James Heaf Herlev Hospital University of Copenhagen Peritoneal Dialysis James Heaf Herlev Hospital University of Copenhagen

Choice of dialysis modality Herlev 2012

Peritonitis-free Survival Denmark 2000-2014

PD as a viable long term dialysis option James Heaf University of Copenhagen Herlev Hospital heaf@dadlnet.dk

The Poor and the Smart Home Dialysis World Leaders 2011 GDP/capita USD 36,667 38,222 10,247 7,855 67,723 56,202 55,158 46,098 5,678 52,232 46,142 38,589 99,622 3,113 38,589 USRDS 2013

Countries with High Home HD Prevalence

Corruption Index Transparency International 2011

Dialysis Costs Danish National Health Service Medical Technology Assessment Report 2006 Aim: 45% on Home Dialysis within 10 years 1 € = 85p www.nephrology.dk

Two basic types Automatic PD, APD CAPD

PD Variations Night Cycler APD CAPD Night (9 hours) Day (15 hours)

CAPD Variations Possibly Night cycler CAPD x 5 Gentle start PD Night (9 hours) Day (15 hours)

APD: Wet and Dry Days APD with wet day APD with Dry day Night (9 hours) Day (15 hours)

Osmotic Pressure and Ultrafiltration Icodextrin Extraneal® 4,25% 2,5% 1,5% KI 62;S81,21 2002

Peritoneal Equilibration Test (PET) Twardowski Perit Dial Bull 7:138 1987 82 68 52

2 year Survival in CAPD CANUSA Studiet. Churchill et al 2 year Survival in CAPD CANUSA Studiet. Churchill et al. J Am Soc Nephrol. 1998; 9:1285-92 Technique Patient Combined Survival Survival Survival Slow Slow average Fast average Fast

PET og Ultrafiltration 2000 ml medium strength (2.2-2.5%) for 4 hours Transport Type UF Slow >650 ml Slow average 370-650 ml Fast Average 85-370 ml Fast <85 ml

Ultrafiltration og transportstatus Neg UF CAPD Night This slide shows the results of computer modeling that characterizes the ultrafiltration (UF) potential of 1.5% dextrose by peritoneal membrane transport pattern—low, low-average, high-average, and high—using actual peritoneal transport data from patients on continuous ambulatory peritoneal dialysis.1 As expected, patients with high transport patterns exhibited the greatest decline in UF potential over time, while those with low transport patterns exhibited the most gradual declines. Nevertheless, during long dwell exchanges of about 10-14 hours, the majority of patients would likely experience negative net UF, regardless of transport status. This is explained by the relatively low concentration of glucose and its rapid diffusion across the peritoneal membrane, resulting in progressive loss of osmotic driving forces.1 APD Day Mujais S, Vonesh E. Kidney Int. 2002;62(suppl 81):S17-S22. 1.5% Glucose 1Mujais S, Vonesh E. Profiling peritoneal ultrafiltration. Kidney Int. 2002;62(suppl 81):S17-S22.

Outcome in high transporters is improved during recent years Commencing 1990-1997 Commencing 1998-2005 Davies SJ, Kidney Int 70: S76-S83, 2006

ADP vs CAPD: Transport Status Multivariate analysis Johnson NDT 25,1973 2010

PD Prevalance Denmark 1990-2010 Mortality

HD vs. PD: Status 2014

PD vs. HD: Effect of Cohort Denmark 1990-2010 Adjusted for age, sex, renal diagnosis Comorbidity, & referral pattern Heaf PlosOne 2014

Effect of Cohort & Diabetes Heaf PlosOne 2014

Effect of Cohort & Age Heaf PlosOne2014

Effect of Cohort & Referral Early Referral Planned, out-patient Dialysis initiation Heaf PlosOne2014

Risk Factors for Residual Renal Function Loss Moist JASN 11:556-565, 2000 ** *** *** * * ** *** *** * *:p<0.05 **:p<0.01 ***:p<0.001 1843 patients 50% PD 50% HD Odds Ratio Multivariate Analyse

Peritoneal and Renal Clearance: Different Effects on Mortality Creatinine Clearance: Change per 1 ml/min Kt/V: Change per 0.1/week

Wu: QOL after 1 Year Wu JASN 15,743 2004 ** * ** ** * * * p<0.05 **p<0.01

CAPD på en tømmerflåde With thanks to Johan Povlsen

Conclusions Economical compared to Center HD Popular in Scandinavia Better patient survival the first two years, possibly due to better preservation of renal function Not a longterm therapy CAPD and APD choice based on transport characteristics and patient wishes A sensible choice for patients who want freedom from hospital and freedom to travel